Selecta Biosciences, Inc.   NASDAQ (SELB)

2.90    $-0.28   -8.81%
At close   Friday, Nov 26 04:00 PM

Selecta Biosciences, Inc. Chart

SELB Stock Price Today

Selecta Biosciences, Inc. (SELB) stock plummeted over -8.81% intraday to trade at $2.90 a share on NASDAQ. The stock opened with a loss of -9.43% at $2.88 and touched an intraday high of $2.9500, declining 7.23% against the last close of $3.18. The stock went to a low of $2.8200 during the session.

Stock Snapshot

3.18
Prev. Close
2.88
Open
348.81M
Market Cap
115.17M
Number of Shares
2.8200
day Low
2.9500
Day High
2.90
-
P/E ratio
8.74%
Free Float in %
-0.48
EPS (TTM)
-0.16
Book Value per Share
1.15
Cash Flow per Share
1.38M
Volume

Selecta Biosciences, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-11-24$3.17$3.18$3.22$3.11659,400
2021-11-23$3.12$3.18$3.20$3.00815,600
2021-11-22$3.25$3.14$3.33$3.13717,300
2021-11-19$3.29$3.21$3.33$3.21748,200
2021-11-18$3.47$3.31$3.51$3.251,046,300
2021-11-17$3.50$3.44$3.62$3.40713,700
2021-11-16$3.59$3.54$3.60$3.45859,000
2021-11-15$3.67$3.59$3.71$3.58723,400
2021-11-12$3.72$3.64$3.80$3.591,025,600
2021-11-11$3.78$3.70$3.78$3.651,105,300
2021-11-10$3.78$3.72$3.82$3.67950,000

Contact Details

65 Grove Street
Watertown, MA 02472
United States
http://selectabio.com
617 923 1400

Company Information

Employees43
Beta0.97
Sales or Revenue67.10M
5Y Sales Change22.50%
Fiscal Year Ends2020-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's proprietary pipeline includes enzymes therapies, gene therapies, and other products and product candidates affected by undesired immune responses. Its lead product is SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout, as well as develops a product candidate to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and IgA vasculitis. The company also engages in the development of gene therapy product candidates that are in preclinical development, including MMA-101, a product candidate for the treatment methylmalonic academia; SEL-313, a product candidate to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to indicate appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and other products for the treatment of pompe disease, duchenne muscular dystrophy, and limb-girdle muscular dystrophy. In addition, it develops a product candidate to treat primary biliary cholangitis. The company has license and collaboration agreements with Swedish Orphan Biovitrum; Spark Therapeutics; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; Asklepios BioPharmaceutical, Inc. Sarepta Therapeutics, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.

Frequently Asked Questions

What is the current Selecta Biosciences, Inc. (SELB) stock price?

Selecta Biosciences, Inc. (NASDAQ: SELB) stock price is $2.90 as of the last check on Friday, Nov 26. During the trading session, SELB stock reached the peak price of $2.9500 while $2.8200 was the lowest point it dropped to.

SELB's industry and sector of operation?

The NASDAQ listed SELB is part of Biotechnology industry that operates in the broader Healthcare sector. Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases.

Who are the executives of SELB?

Dr. Carsten Brunn
CEO, Pres & Director

Dr. Ulrich H. von Andrian-Werburg M.D., Ph.D.
Co-Founder and Co-Chair of the Scientific Advisory Board

Mr. Bradford D. Dahms
CFO, Principal Financial Officer & Principal Accounting Officer

Dr. Lloyd Johnston
COO and Sr. VP of R&D


What is the SELB stock price today?

SELB stock traded closed the last session at $2.90, which is $-0.28 or -8.81% lower than its previous close of $3.18. SELB's current trading price is -49.12% lower than its 52-week high of $5.70 where as its distance from 52-week low of $2.67 is 8.61%.

How many employees does SELB have?

Number of SELB employees currently stands at 43. SELB operates from 65 Grove Street Watertown, MA 02472 United States.

Link for SELB official website?


How do I contact SELB?

SELB could be contacted at 65 Grove Street Watertown, MA 02472 United States, or at phone # 617 923 1400 and can also be accessed through its website: http://selectabio.com

How many shares of SELB are traded daily?

SELB stock volume for the day was 1.38M shares while in the previous session number of SELB shares traded was 659400. The average number of SELB shares traded daily for last 3 months was 889940.

How much did SELB change today?

The percentage change in SELB stock occurred in the recent session was -8.81% while the dollar amount for the price change in SELB stock was $-0.28.

What price range SELB stock been trading in?

In the recent session, the day high for SELB stock was $2.9500 while the low for SELB stock touched on the day was $2.8200.

What is the market cap of SELB currently?

The market value of SELB currently stands at $348.81M with its latest stock price at $2.90 and 115.17M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam